Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, Clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more. OMICS International Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma and Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more scientific societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
According to Greater Philadelphia Regional 2013 report, the region is home to nearly 1,200 Life Science establishments from global pharmaceutical leaders to medical device and diagnostics to biotech and contract research organizations. Home to 101 degree-granting institutions, Greater Philadelphia ranks as one of the nation’s leading centres for higher education with a total of 91,844 degrees and certificates awarded. The Greater Philadelphia region is among the nation’s top 5 research and development (R&D) centres by spending according to Select Greater Philadelphia’s Research & Development Study conducted in 2011. Greater Philadelphia’s private sectors made up the bulk of this spending with a total of $8.9 billion, followed by colleges and universities which accounted for more than $1.3 billion in spending. Top Fortune 1,000 Companies are headquartered in the region with 1,000+ employees. According to market and market report the global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019. As per a report, In 2013 North America was the market leader with a share of 42% of the global metabolomics market.
For more details, please visit: Metabolomics Analysis Report